Healthcare
The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.
Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....
Key Topics Covered in Healthcare:
Drug Development & Innovation:
- Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
- Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
- Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
- Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.
Digital Health & Telehealth:
- Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
- Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
- Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
- Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
- Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.
Medical Devices & Diagnostics:
- Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
- Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
- Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
- Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
- Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
- Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
- Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
- Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
- Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
- Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
- Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.
Other Healthcare Growth Areas:
- Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
- Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.
Clinical Trials & Drug Development Services:
- Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
- Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.
Biopharmaceutical Products:
- Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
- Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.
For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.
-
01 Jun 2026  |  Global  |  Market Research
Biopharma Patient Access Market, Global, 2026
Access-Controlled Commercialization is Experiencing Transformational Growth due to Rising Specialty Therapy Complexity
The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...
$2,450.00 -
28 May 2026  |  Global  |  Market Research
Growth Opportunities in the Electrophysiology Ablation Devices Market, Global, 2023–2031
New-Age Technologies are Driving Transformational Growth
This study focuses on the global electrophysiology (EP) ablation devices market. It analyzes the market for catheter-based ablation technologies used primarily to treat cardiac arrhythmias (especially atrial fibrillation), including radiofrequency (RF), cryoablation, pulse field ablation (PFA), and emerging modalities.The global EP ablation devices...
$4,950.00 -
21 May 2026  |  Global  |  Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00 -
11 May 2026  |  Global  |  Market Research
Home Care Digitization Market, United States and Europe, 2026–2031
The Shift from Episodic to Intelligent, Data-driven Care is Driving Transformational Growth by Enabling Continuous, Risk-Driven Home Care
Home care digitalization continues to gain strong momentum, driven by the rapid growth of the elderly population, increasing prevalence of multi-morbidity, persistent workforce shortages, and rising cost and efficiency pressures on payers and public health systems. Population aging is not only increasing the volume of home care but also its complex...
$4,950.00 -
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
28 Apr 2026  |  Global  |  Market Research
Global Digital Health Solutions for Behavioral Health Management, Forecast to 2031
Platformization, Enterprise Adoption, and AI-Enabled Care are Redefining Behavioral Health Delivery
The global digital health solutions market for behavioral health management is demonstrating steady and sustained growth, driven by rising demand for accessible, scalable mental health services across employers, payers, and health systems. Persistent workforce shortages, increasing prevalence of mental health conditions, and growing recognition of ...
$4,950.00 -
22 Apr 2026  |  Global  |  Market Research
Top Growth Opportunities: European Congress of Radiology (ECR) 2026
AI-Integrated Ecosystem and Sustainable Solutions are Key Themes
The European Congress of Radiology (ECR) 2026 in Vienna highlighted the transformative role of artificial intelligence (AI) in imaging, advances in personalized medicine, and sustainability in healthcare. The theme “Rays of Knowledge” emphasized education, innovation, and collaboration across disciplines, with a record-high attendance and over 11,0...
$2,450.00 -
22 Apr 2026  |  Global  |  Market Research
Top 5 Key Takeaways from the Scope Summit, 2026
AI Adoption in Clinical Research has Moved from Exploration to Execution
The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...
$2,450.00 -
20 Apr 2026  |  Global  |  Market Research
HIMSS 2026: Five Key Takeaways and Growth Opportunities
From Innovation to Execution: Scaling AI, Data, and Workflows in Healthcare
HIMSS 2026, held in Las Vegas, brought together 24,000+ stakeholders and 900+ exhibitors, underscoring the growing urgency for healthcare organizations to translate digital investments into measurable outcomes amid cost pressures, workforce shortages, and rising care complexity. Discussions at the event highlighted a clear shift from innovation-led...
$2,450.00 -
15 Apr 2026  |  Global  |  Market Research
ViVE 2026: Key Takeaways and Growth Opportunities
Scalability and Enterprise Alignment will Decide the Viability of AI Companies in Healthcare
ViVE 2026, held February 22–25 in Los Angeles, brought together more than 7,000 attendees, 230+ speakers, and 300 exhibitors to define the year’s direction in digital health. It reinforced a pivotal message for the healthcare IT ecosystem: AI has moved beyond experimentation and is now a core enterprise capability requiring scale, governance, and a...
$2,450.00